Contaminant Discovered In Chinese-Produced Heparin API
This article was originally published in PharmAsia News
Executive Summary
U.S FDA has discovered "significant quantities" of a heparin-like contaminant in tested samples of heparin API manufactured by Baxter-supplier Scientific Protein Laboratories' Changzhou plant